122 related articles for article (PubMed ID: 35758332)
21. [Effect of Dimethyl Fumarate (DMF) on T-cell Acute Lymphoblastic Leukemia].
Xu JG; Cheng Q; Zhang GH; Kong LP; Li L; Liu KG; Wu JY; Zhang QR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):1-5. PubMed ID: 35123595
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
Li S; Juco J; Mann KP; Holden JT
Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
[TBL] [Abstract][Full Text] [Related]
23. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells.
Monma F; Nishii K; Ezuki S; Miyazaki T; Yamamori S; Usui E; Sugimoto Y; Lorenzo V F; Katayama N; Shiku H
Cancer Genet Cytogenet; 2006 Jan; 164(2):118-21. PubMed ID: 16434313
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of AIOLOS induces apoptosis and enhances etoposide chemosensitivity in Jurkat leukemia cells.
Zhuang Y; Lu Y; Li D; Sun N; Ju X
Oncol Rep; 2015 Mar; 33(3):1319-25. PubMed ID: 25524659
[TBL] [Abstract][Full Text] [Related]
25. 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies.
Xu Y; Liu Q; Zhong M; Wang Z; Chen Z; Zhang Y; Xing H; Tian Z; Tang K; Liao X; Rao Q; Wang M; Wang J
J Hematol Oncol; 2019 May; 12(1):49. PubMed ID: 31097020
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.
Mets E; Van Peer G; Van der Meulen J; Boice M; Taghon T; Goossens S; Mestdagh P; Benoit Y; De Moerloose B; Van Roy N; Poppe B; Vandesompele J; Wendel HG; Van Vlierberghe P; Speleman F; Rondou P
Haematologica; 2014 Aug; 99(8):1326-33. PubMed ID: 24895337
[TBL] [Abstract][Full Text] [Related]
27. BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?
Kawashima-Goto S; Imamura T; Tomoyasu C; Yano M; Yoshida H; Fujiki A; Tamura S; Osone S; Ishida H; Morimoto A; Kuroda H; Hosoi H
PLoS One; 2015; 10(7):e0132926. PubMed ID: 26172269
[TBL] [Abstract][Full Text] [Related]
28. Initial characterization of an anti-CD5 monoclonal antibody obtained from leukemic cells infiltrating lymphocytes.
Delfini C; Centis F; Muretto P; Staccioli MP; Pazzaglia C
Haematologica; 1993; 78(3):145-50. PubMed ID: 7690732
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of CD5 antigen modulation by 12-O-tetradecanoylphorbol-13-acetate in T-lymphoblastic leukemia cells: individual response patterns and their relationships with both maturation and protein kinase C content.
Chiron M; Darbon JM; Roubinet F; Cassar G; Jaffrezou JP; Bordier C; Laurent G
Cell Immunol; 1990 Oct; 130(2):339-51. PubMed ID: 1698561
[TBL] [Abstract][Full Text] [Related]
30. Expression pattern of CD45 RA/RO isoformic antigens in T-lineage neoplasms.
Kawano S; Tatsumi E; Yoneda N; Tani A; Nakamura F
Am J Hematol; 1995 May; 49(1):6-14. PubMed ID: 7741140
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
[TBL] [Abstract][Full Text] [Related]
32. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.
Oliveira LH; Schiavinato JL; Fráguas MS; Lucena-Araujo AR; Haddad R; Araújo AG; Dalmazzo LF; Rego EM; Covas DT; Zago MA; Panepucci RA
Cancer Sci; 2015 Oct; 106(10):1264-77. PubMed ID: 26251039
[TBL] [Abstract][Full Text] [Related]
33. [Synergistic cytotoxic effects of rapamycin and idarubicin on human acute T-cell lymphoblastic leukemia Jurkat cells].
Zhao YM; Wu KN; Wang YJ; Wu GQ; Cao WJ; Yu XH; Huang H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 40(5):482-8. PubMed ID: 21984149
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
Qian L; Zhang W; Lei B; He A; Ye L; Li X; Dong X
Oncol Rep; 2016 Nov; 36(5):2511-2516. PubMed ID: 27666896
[TBL] [Abstract][Full Text] [Related]
35. B-Lymphoblastic Leukemia With Aberrant CD5 Expression.
Ye MT; Zhu J; Luo DX; Wang Y; Chen Z; Yang Y; Tian C; Zhang Y; You MJ
Am J Clin Pathol; 2021 Sep; 156(4):586-595. PubMed ID: 33822875
[TBL] [Abstract][Full Text] [Related]
36. Effects of interleukins 1-7 on the proliferation of T-lineage acute lymphoblastic leukemia cells.
Masuda M; Takanashi M; Motoji T; Oshimi K; Mizoguchi H
Leuk Res; 1991; 15(12):1091-6. PubMed ID: 1766257
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with miR-34a and doxorubicin synergistically induced apoptosis in T-cell acute lymphoblastic leukemia cell line.
Najjary S; Mohammadzadeh R; Mansoori B; Vahidian F; Mohammadi A; Doustvandi MA; Khaze V; Hajiasgharzadeh K; Baradaran B
Med Oncol; 2021 Oct; 38(12):142. PubMed ID: 34655330
[TBL] [Abstract][Full Text] [Related]
38. The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia.
Chen H; Wang N; Yang G; Guo Y; Shen Y; Wang X; Zhang P; Xu Y
Leuk Res; 2016 Mar; 42():28-36. PubMed ID: 26859780
[TBL] [Abstract][Full Text] [Related]
39. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.
Gazon H; Belrose G; Terol M; Meniane JC; Mesnard JM; Césaire R; Peloponese JM
Oncotarget; 2016 May; 7(21):30258-75. PubMed ID: 26849145
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
